Parkinson's Medications: Dopamine Agonists, MAO-B Inhibitors, and More (2020)
In this webinar, Pharmacist Amy Tran covers dopamine agonists and their role in addressing Parkinson's motor symptoms. She highlights factors affecting medication selection, like symptom severity and daily impact. Amy explains dopamine agonists' mechanism, motor complications, and their associated side effects, emphasizing shared decision-making in therapy choice.
The talk delves into Parkinson's medication side effects and counseling points, citing sudden sleep attacks and impulse control issues with dopamine agonists. It details Apomorphine's role in off episodes and discusses MAO-B inhibitors' use, potential insomnia, and dyskinesia side effects. Additionally, it explores COMT inhibitors' function in reducing levodopa clearance and managing wearing off symptoms.
Additionally, she covers varied Parkinson's medications like COMT inhibitors, anticholinergics, and amantadine, each with unique mechanisms and side effects. The importance of tailoring medication to individual needs is stressed, considering the uniqueness of each Parkinson's case.
View the video slides accompanying this presentation by clicking here.
**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**